Anti-CLIC3 antibody [EPR8244(B)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CLIC3 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 1 publication.
View Alternative Names
Chloride intracellular channel protein 3, Glutaredoxin-like oxidoreductase CLIC3, CLIC3
- WB
Unknown
Western blot - Anti-CLIC3 antibody [EPR8244(B)] (AB129186)
All lanes:
Western blot - Anti-CLIC3 antibody [EPR8244(B)] (ab129186) at 1/1000 dilution
Lane 1:
JAR lysates at 10 µg
Lane 2:
Rat kidney lysates at 10 µg
Lane 3:
Mouse kidney lysates at 10 µg
Lane 4:
Human fetal kidney lysates at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 27 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Allergologia et immunopathologia 52:46-52 PubMed38970264
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com